Potential Ameliorating Role of Spironolactone in Trastuzumab-induced Cardiotoxicity: A Narrative Review
Background: Around 20% of breast cancers (BCs) overexpress Human Epidermal Growth Factor Receptor 2 (HER-2). HER-2 overexpression is associated with increased tumor aggressiveness and poor prognosis. Trastuzumab (an anti-HER2 monoclonal antibody) has been reported to improve overall survival in earl...
Guardat en:
| Autors principals: | , , , |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Shaheed Beheshti University of Medical Sciences
2021-11-01
|
| Col·lecció: | International Journal of Medical Toxicology and Forensic Medicine |
| Matèries: | |
| Accés en línia: | https://journals.sbmu.ac.ir/ijmtfm/article/view/36127 |
| Etiquetes: |
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|
